Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2019-04-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于公司实际控制人股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the company's actual controller, Mr. Guan Yanbin. It details the number of shares released from pledge, dates, and related parties. The document is short (1249 characters) and focuses on share pledge status changes, not on financial results, management changes, or other report types. It is not a full financial report, earnings release, or management report. It is a regulatory announcement about share pledge status, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Major Shareholding Notification (MRQ) because it concerns pledge release, not share ownership threshold changes. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2019-04-29 Chinese
关于公司实际控制人部分股份被冻结的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the freezing of shares held by the company's actual controller due to a legal dispute. It details the number of shares frozen, the reasons for the freeze, and the impact on control and operations. There are no financial statements, earnings data, or report attachments. The document is a regulatory announcement about shareholding status and legal matters affecting shares, not a financial report or voting result. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 2000 characters, consistent with a brief announcement rather than a full report.
2019-04-29 Chinese
第三届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2019 first quarter report. It states that the Supervisory Board has reviewed and approved the full text and content of the quarterly report, confirming its compliance and accuracy. The document itself does not contain the actual financial statements or substantive financial data of the quarterly report but is an announcement of the approval of that report. The document length is short (710 characters), and it serves as a formal announcement of the Supervisory Board's resolution rather than the report itself. Therefore, according to the MENU VS MEAL rule, this is not the quarterly report but an announcement related to it. The best fitting category is Regulatory Filings (RNS), as it is a regulatory announcement about the approval of a report, not the report itself.
2019-04-22 Chinese
第三届董事会第十五次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a formal announcement of the board of directors' meeting resolution approving the company's 2019 first quarter report. It states that the full quarterly report has been disclosed on official information platforms and that the board has approved the financial report for external release. The document itself does not contain the financial data or the full report but serves as an official notice of the board's approval and the report's publication. The document length is short (896 characters), and it primarily announces the approval and disclosure of the quarterly report rather than presenting the report itself. Therefore, according to the MENU VS MEAL RULE, this is a Report Publication Announcement (RPA).
2019-04-22 Chinese
2019年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 年第一季度报告全文" which translates to "2019 First Quarter Report Full Text." It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes on financial performance for the first quarter of 2019. The document includes comprehensive financial metrics, shareholder information, management statements, and detailed financial tables. The length is substantial (15,000 characters) and it contains actual financial statements and substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-22 Chinese
2019年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of 葵花药业集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as revenue, net profit, cash flow, assets, liabilities, and shareholder information for the first quarter of 2019. The length of the document (12,575 characters) and the presence of comprehensive financial tables and management commentary confirm it is a substantive financial report rather than a brief announcement or certification. The content matches the definition of an Interim / Quarterly Report (IR), which includes actual financial statements and analysis for a period shorter than a full fiscal year. Therefore, the correct classification is IR. Q1 2019
2019-04-22 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.